4098 studies found for:    Lung Diseases, Obstructive
Show Display Options
Rank Status Study
21 Completed Pre-Discharge Bundle for Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease to Reduce Readmissions
Conditions: Chronic Obstructive Pulmonary Disease;   Exacerbation of Chronic Obstructive Pulmonary Disease
Intervention: Behavioral: Bundle tool
22 Completed
Has Results
Long-term Safety, Tolerability and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-35)
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: aclidinium bromide
23 Completed
Has Results
Long-term Extension Study of the Safety, Tolerability, and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-36)
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: Aclidinium bromide
24 Completed To Assess the Long-term Safety, Efficacy and Tolerability of Inhaled Aclidinium Bromide in the Treatment of Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Aclidinium bromide;   Drug: Placebo
25 Completed Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Aclidinium Bromide/Formoterol Fumarate;   Drug: Aclidinium Bromide;   Drug: Formoterol Fumarate;   Drug: Placebo
26 Completed
Has Results
1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Glycopyrronium bromide;   Drug: Placebo to glycopyrronium bromide;   Drug: Tiotropium
27 Completed
Has Results
The Effect of Indacaterol on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Indacaterol 300 μg;   Drug: Placebo
28 Active, not recruiting Oral Cyclosporine in Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: Cyclosporine
29 Not yet recruiting Treatment in Patients Hospitalized With Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Intervention:
30 Terminated Disease Management in Asthma or Chronic Obstructive Pulmonary Disease (COPD) Patients
Conditions: Chronic Obstructive Pulmonary Disease (COPD);   Asthma
Interventions: Other: Pulmonary disease management;   Other: Usual care
31 Completed
Has Results
Cardiac Limitations in Chronic Obstructive Pulmonary Disease: Benefits of Bronchodilation
Conditions: Chronic Obstructive Pulmonary Disease;   COPD
Interventions: Drug: Tiotropium;   Drug: Placebo
32 Recruiting Czech Multicentre Research Database of Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Airway Disease
Intervention:
33 Recruiting Boston Early-Onset Chronic Obstructive Pulmonary Disease (COPD) Study
Condition: Chronic Obstructive Pulmonary Disease
Intervention:
34 Completed Endothelial Dysfunction and Chronic Obstructive Pulmonary Disease
Conditions: Chronic Obstructive Pulmonary Disease;   Endothelial Dysfunction
Intervention:
35 Completed Metformin in Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Metformin;   Drug: Placebo
36 Completed
Has Results
Safety Study of Cell Therapy to Treat Chronic Obstructive Pulmonary Disease
Conditions: Chronic Obstructive Pulmonary Disease;   Pulmonary Emphysema
Interventions: Drug: Stem cells stimulation;   Procedure: stem cells collection;   Genetic: stem cells infusion
37 Completed
Has Results
Safety and Tolerability of 28 Days Treatment With Glycopyrronium Bromide (NVA237) (100 or 200 µg Once a Day) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: NVA237 100 µg;   Drug: Placebo;   Drug: NVA237 200 µg
38 Unknown  Inhaler Lung Deposition in Chronic Obstructive Pulmonary Disease (COPD)
Conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE;   ASTHMA;   HEALTHY SUBJECTS
Intervention: Drug: SALBUTAMOL
39 Completed Safety of Ramelteon in Subjects With Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: Ramelteon and Placebo
40 Completed Safety of Ramelteon in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease
Conditions: Chronic Obstructive Pulmonary Disease;   COPD
Intervention: Drug: Ramelteon and Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years